VICTORIA, April 5, 2017 /CNW/ - Emerald Health
Therapeutics Inc. (TSXV:EMH) ("Emerald" or the "Company") is
pleased to announce its inclusion in the Horizon Medical Marijuana
Life Sciences ETF (TSX:HMMJ) ("HMMJ ETF"), which began trading
today and is the first ETF to offer direct exposure to North
American-listed stocks that operate in the legal medical cannabis
industry.
The HMMJ ETF seeks to replicate the performance of the North
American Medical Marijuana Index of which we are one of the 16
constituents. Only stocks that meet minimum asset and liquidity
thresholds are qualified for inclusion in the index, and no single
stock may exceed 10% of the weight of the Index when
rebalanced.
"Emerald's inclusion to the North American Medical Marijuana
Index and HMMJ ETF represents an important milestone for our
company and highlights the enormous efforts and successes of our
team," said Avtar Dhillon, Executive
Chairman. "Inclusion in the ETF should encourage broader
participation in Emerald's shares, improving trading liquidity for
our shareholders, as well as drive more funds to the cannabis
sector on the whole, increasing awareness of the publicly traded
companies and providing a more passive and diversified method for
investors to participate in the truly unique cannabis investment
opportunity."
This milestone compliments the company's breakout year in 2016,
which earned Emerald a ranking of 3rd Place in the Clean Technology
& Life Science sector of the 2017 TSX Venture 50® (see here),
an award in recognition of being a top performer on the TSXV.
For more information on the constituents that are expected to
make up the ETF's holdings, visit Horizon Exchange Traded Funds
website here.
Join us on our journey of enhancing health through
cannabis science.
For more information, explore our website and investor
presentation at emeraldhealth.ca
Emerald Health Therapeutics Inc.
Emerald Health Therapeutics, Inc. operates primarily through
Emerald Health Botanicals Inc. ("Botanicals"), a wholly owned
subsidiary of the Company and a Licensed Producer under the Access
to Cannabis for Medical Purposes Regulations (the "ACMPR").
Botanicals is authorized to cultivate and sell both dried medical
cannabis flowers and medical cannabis oils in Canada. Botanicals currently operates an
indoor cultivation facility in Victoria,
British Columbia, and plans to construct a much larger
purpose built hybrid greenhouse facility on 32 acres in metro
Vancouver. Botanicals prides
itself on being one of Canada's
most medically focused licensed producers and on having one of the
industry's most qualified management teams with respect to
pharmaceutical drug discovery, development and distribution.
Botanicals intends to capture unique niches in both the medical and
future adult use cannabis markets through its proprietary strains,
defensible intellectual property, and superb client experience.
"Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release."
SOURCE Emerald Health Therapeutics, Inc.